Authors: Alison J. Price , DPhil, F. Lucy Wright , DPhil, Jane Green , DPhil, Angela Balkwill , MSc, Sau Wan Kan , MSc, TienYu Owen Yang , DPhil, Sarah Floud , PhD, Mary E. Kroll , DPhil, Rachel Simpson , MB, BCh, Cathie L.M. Sudlow , FRCP(E), Valerie Beral , FRS, Gillian K. Reeves , PhD
Publication date PMC-release 23 January 2018
Publisher: Lippincott Williams & Wilkins
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Wellcome Trust, Postdoctoral Research Training Fellowship
(1)Medical Research Council (UK), grant no. MR/K02700X/1, co-PI, 2013-2018
(1) Cancer Research UK, Programme Grant no. C570/A16491, co-PI, 2014-2019
Husband of author: scientific advisory board of 'Meningitis Now' (a UK charity, i.e. non-profit)
Husband of author: Biomedical Research Centre, Imperial Healthcare NHS Trust, UK
(1) UK MRC and Wellcome Trust: UK Biobank programme renewal, ?35 million, 2010-2017 (co-I) (2) UK MRC, Dementias Platform UK programme grant, ?12 million, 2014-2019 (co-I) (3) UK MRC, Wellcome Trust, British Heart Foundation: UK Biobank imaging study, ?43 million, 2013-2022 (co-I) (4) European Union Innovative Medicines Initiative Horizon 2020 programme, ROADMAP (real world outcomes in Alzheimer's Disease), 8 million euros (about 50% EU, 50% EFPIA pharma company partners), 2016-2018 (co-I)
(1) British Heart Foundation, 2012-2017, RESTART trial of antiplatelet treatment in ICH ( co-I)
(1) Non-Executive Director, Medicines and Healthcare Regulatory Products Regulatory Agency
(1) Was a member of the Grail Inc. Population Study Scientific Advisory Board (2017).
(1) Medical Research Council, grant no MR/K02700X/1, Co-PI, Programme grant to support the Million Women Study cohort, 2013-2018.
(1) Cancer Research UK, grant no C570/A16491, Co-PI, Programme Grant to support the work of the Cancer Epidemiology Unit, 2014-2017.
This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.